Applied Morphomics, Inc. ( AMI ) is a biomarker technology and development company targeting assessment of body factors essential for delivering precision medicine. AMI technology, Analytic Morphomics®, integrates 10 years of research from the the company founder's lab at the University of Michigan Medical School to reveal objective and granular internal measurement of the body. AMI’s mission is to make the next generation of digital biomarker technology available to the greater healthcare community.